Thus, these observations, combined, indicate that 5210-87-13 mAb has the capacity to label nuclear A3B in neoplastic cells and additionally react with cytoplasmic A3G and A3A in tumor-infiltrating lymphocytes (TILs) and tumor-associated monocytes/macrophages, respectively. Here, APOBEC3A is linked to neoplasm.